MIRA INFORM REPORT

 

 

Report No. :

343513

Report Date :

08.10.2015

 

IDENTIFICATION DETAILS

 

Name :

FARMACEUTICA INTERNACIONAL, S.A. DE C.V.

 

 

Registered Office :

Barrio La Granja, Edificio Farinter, atrás de Corporación Flores, Comayaguela,

 

 

Country :

Honduras

 

 

Date of Incorporation :

1968

 

 

Legal Form :

Sociedad Anónima de Capital Variable

 

 

Line of Business :

Subject is dedicated to the trade and distribution of cosmetics, pharmaceuticals, medical equipment.

 

 

No. of Employee :

1 000

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 100 000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Honduras

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

HONDURAS ECONOMIC OVERVIEW

 

Honduras, the second poorest country in Central America, suffers from extraordinarily unequal distribution of income, as well as high underemployment. While historically dependent on the export of bananas and coffee, Honduras has diversified its export base to include apparel and automobile wire harnessing. Honduras’s economy depends heavily on USTRADE and remittances. The US-Central America-Dominican Republic Free Trade Agreement (CAFTA-DR) came into force in 2006 and has helped foster foreign direct investment, but physical and political insecurity, as well as crime and perceptions of corruption, may deter potential investors; about 15% of foreign direct investment is from US firms. The economy registered modest economic growth of 2.6%-4.0% from 2010 to 2014, insufficient to improve living standards for the nearly 65% of the population in poverty. Honduras signed a three-year IMF stand-by arrangement in December 2014 that will help ease its poor fiscal position. In November 2014 along with his counterparts from El Salvador and Guatemala, President HERNANDEZ announced the “Plan of the Alliance for Prosperity in the Northern Triangle.” This plan seeks to address the challenges facing the three Northern Triangle countries, including steps the governments will take to stimulate economic growth, increase transparency and fiscal responsibility, reduce violence, modernize the justice system, improve infrastructure, and promote educational opportunities over the next several years.

 

Source : CIA

 

STATUTORY INFORMATION

 

Legal Name:

FARMACEUTICA INTERNACIONAL, S.A. DE C.V.

Trade Name:

Farinter
Drogueria Farinter S.A. de CV

RTN:

8019003242474   

Date Created:

1968

Date Incorporated:

1968

Legal Address:

Barrio La Granja, Edificio Farinter, atrás de Corporación Flores, Comayaguela, Honduras

Operative Address:

Barrio La Granja, Edificio Farinter, atrás de Corporación Flores, Comayaguela, Honduras

Telephone:

2225-2718

Fax:

2225-2732

Legal Form:

Sociedad Anónima de Capital Variable

Email:

kfaraj@farinter.hn

Registered in:

Honduras

Website:

www.farinter.hn

Contact:

Karim Faraj Richmawy, President

Staff:

1 000

Activity:

Pharmaceutical Manufacturing Industry

 

 

 

 

BANKS

Bnaco Central de Honduras

 

 

 

The company does not disclose its banking information

 

 

History

 

 

Farmaceutica Internacional, better known by its acronym FARINTER is a corporation founded in 1968.

 

 

PRINCIPAL ACTIVITY

 

 

The company is dedicated to the trade and distribution of cosmetics, pharmaceuticals, medical equipment.

Products/Services description:

Cosmetics, pharmaceuticals, medical equipment.

Brands:

Alcon
Fleet
Bayer
Almirall
Aventis
Roche
Detctor
OM
Leo
SANOFI
3M
EUROMED
BAGO
WYETH
MSD
NOVARTIS

Sales are:

Wholesale

Clients:

BLAU FARMACEUTICA COLOMBIA SAS
Colombia

Suppliers:

EVENFLO MEXICO SA DE CV
Mexico

UNILEVER DE MEXICO SA DE CV
Mexico

PROCAPS S.A
Colombia

LABORATORIOS BUSSIE SA
Colombia

MEAD JOHNSON NUTRICIONALES 
Mexico

GENOMMALAB ECUADOR SA
Ecuador

Operations area:

National and International

The company imports from

Colombia, Ecuador, Mexico

The company exports to

Colombia 

The subject employs

1 000 employees

Payments:

No Complaints

Partners:

Droguería Medilab & Grupo Financiero Ficohsa

 

 

LOCATION

 

Headquarters :

Barrio La Granja, Edificio Farinter, atrás de Corporación Flores, Comayaguela, Honduras

Branches:

Col. Santa Rosa, 7 y 8 Calle, Segundo Anillo  Circumvalacion, Honduras

Sister Companies:

KIELSA
VAVER
COINSA
MEDILAB
EUROMED

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO

Shareholders:

This is a private company. It is controlled by:

GRUPO FARINTER
Honduras

Major holder of said group is:
Eduardo Faraj

Management:

Karim Alejandro Faraj Farach, Counsel Secretary
Henry Soto, Credit Controller
Karim Faraj Richmawy, President
Eduardo Alberto Faraj Farach, Counsel Member
Ivan Alejandro Faraj Farach,  Counsel Member
Lizzethe De Faraj,  Counsel Member
Lorena Lizzethe Faraj, Counsel Member
Doris De Lara, Controller

 

 

FINANCIAL INFORMATION

 

 

This is a private company which does not make its financials public. The following information has been provided by the controllers of the company:

 

 

2014 USD

 

Revenue

70 572 000

Net Income

729 000

Total Equity

27 519 500

 

 

LEGAL FILINGS

 

 

There are no legal for the subject

 

 

SUMMARY

 

 

The company is dedicated to the trade and distribution of cosmetics, pharmaceuticals, medical equipment.

 

It has 47 years of experience in the market with a large sized structure. It is related to other 4 companies belonging to the same group.

 

The company is well established in the market operating with well known suppliers and brands. 

 

 

RISK INFORMATION

 

DEBTS

Controlled

PAYMENTS

No Complaints

CASH FLOW

Normal

SUGGESTED CREDIT LINE

USD 100 000

STATUS

Active

 

 

INTERVIEW

 

NAME

NA 

POSITION

Administrative 

COMMENTS

The person contacted confirmed managers, activity, brand, RTN, group and Suppliers. 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.65.26

UK Pound

1

Rs.99.53

Euro

1

Rs.73.47

 

 

INFORMATION DETAILS

 

Analysis Done by :

KIN

 

 

Report Prepared by :

ANK

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.